Related references
Note: Only part of the references are listed.Impact of Sunitinib on Human Thyroid Cancer Cells
Jirka Grosse et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
The Impact of Altered Gravity and Vibration on Endothelial Cells During a Parabolic Flight
Markus Wehland et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Interleukin-6 Expression under Gravitational Stress Due to Vibration and Hypergravity in Follicular Thyroid Cancer Cells
Xiao Ma et al.
PLOS ONE (2013)
Gene Networks Modified by Sulphonylureas in Beta Cells: A Pathway-based Analysis of Insulin Secretion and Cell Death
Nils E. Magnusson et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2012)
Target-based Anti-angiogenic Therapy in Breast Cancer
Markus Wehland et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Short-term weightlessness produced by parabolic flight maneuvers altered gene expression patterns in human endothelial cells
Jirka Grosse et al.
FASEB JOURNAL (2012)
Gravity-sensitive signaling drives 3-dimensional formation of multicellular thyroid cancer spheroids
Jirka Grosse et al.
FASEB JOURNAL (2012)
EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis
Tobias Ettl et al.
HUMAN PATHOLOGY (2012)
Activation of the RAS/RAF/ERK Signaling Pathway Contributes to Resistance to Sunitinib in Thyroid Carcinoma Cell Lines
Annamaria Piscazzi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis
Giuseppe Pasqualetti et al.
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2012)
Targeting Signal Transducer and Activator of Transcription 3 Pathway by Cucurbitacin I Diminishes Self-Renewing and Radiochemoresistant Abilities in Thyroid Cancer-Derived CD133+ Cells
Ling-Ming Tseng et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Drugs Interfering with Apoptosis in Breast Cancer
Daniela Grimm et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
New therapeutic options for advanced thyroid cancer
M. J. Willhauck et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2011)
Apoptosis in cancer: from pathogenesis to treatment
Rebecca S. Y. Wong
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Differential Role of PKA Catalytic Subunits in Mediating Phenotypes Caused by Knockout of the Carney Complex Gene Prkar1a
Zhirong Yin et al.
MOLECULAR ENDOCRINOLOGY (2011)
Phase II Study of Daily Sunitinib in FDG-PET-Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation
Laurie L. Carr et al.
CLINICAL CANCER RESEARCH (2010)
Sunitinib Induces Apoptosis and Growth Arrest of Medulloblastoma Tumor Cells by Inhibiting STAT3 and AKT Signaling Pathways
Fan Yang et al.
MOLECULAR CANCER RESEARCH (2010)
Changes of Apoptosis, p53, and bcl-2 by Irradiation in Poorly Differentiated Thyroid Carcinoma Cell Lines: A Prognostic Marker for the Prospect of Therapeutic Success?
Fabian Pohl et al.
THYROID (2010)
Sunitinib Inhibits MEK/ERK and SAPK/JNK Pathways and Increases Sodium/Iodide Symporter Expression in Papillary Thyroid Cancer
Mike S. Fenton et al.
THYROID (2010)
Blockade of Neoangiogenesis, a New and Promising Technique to Control the Growth of Malignant Tumors and their Metastases
Daniela Grimm et al.
CURRENT VASCULAR PHARMACOLOGY (2009)
Radiolabeled annexin V for imaging apoptosis in radiated human follicular thyroid carcinomas - is an individualized protocol necessary?
Jirka Grosse et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model
Guru Sonpavde et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Innovative strategies in in vivo apoptosis imaging
Johann Schoenberger et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Extracellular signal-regulated kinase activation by Neisseria gonorrhoeae downregulates epithelial cell proapoptotic proteins bad and bim
Heather L. Howie et al.
INFECTION AND IMMUNITY (2008)
Expression of vascular endothelial growth factor and receptor tyrosine kinases in cardiac ischemia/reperfusion injury
Manfred Infanger et al.
CARDIOVASCULAR PATHOLOGY (2007)
New therapeutic approaches for metastatic thyroid carcinoma
Eric Baudin et al.
LANCET ONCOLOGY (2007)
Sunitinib: From rational design to clinical efficacy
Laura Q. M. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy
C. Durante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity
Shem Patyna et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Survivin, a cancer target with an emerging role in normal adult tissues
Seiji Fukuda et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Pathogenetic mechanisms in thyroid follicular-cell neoplasia
T Kondo et al.
NATURE REVIEWS CANCER (2006)
Mechanisms of apoptosis after ischemia and reperfusion: Role of the renin-angiotensin system
P Kossmehl et al.
APOPTOSIS (2006)
Survival and death causes in differentiated thyroid carcinoma
CFA Eustatia-Rutten et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Thyroid cancer review 2: management of differentiated thyroid cancers
P Nix et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer
F Rödel et al.
CANCER RESEARCH (2005)
Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells
T Liu et al.
ONCOGENE (2004)
The Bcl-2 family: roles in cell survival and oncogenesis
S Cory et al.
ONCOGENE (2003)
Weightlessness induced apoptosis in normal thyroid cells and papillary thyroid carcinoma cells via extrinsic and intrinsic pathways
P Kossmehl et al.
ENDOCRINOLOGY (2003)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells
LM Mooney et al.
BRITISH JOURNAL OF CANCER (2002)
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer
N Zaffaroni et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Complexities in the development of cyclin-dependent kinase inhibitor drugs
EA Sausville
TRENDS IN MOLECULAR MEDICINE (2002)
An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7
S Shin et al.
BIOCHEMISTRY (2001)
Share Paper
